Acrinova AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 38.62 million compared to SEK 33.79 million a year ago. Revenue was SEK 38.82 million compared to SEK 34.45 million a year ago.

Net income was SEK 2.03 million compared to SEK 0.113 million a year ago. Basic earnings per share from continuing operations was SEK 0.03. Diluted earnings per share from continuing operations was SEK 0.03.